rcca-header
Clinical Trials

A Phase 2 Study of Brentuximab Vedotin Plus Cyclophosphamide, Doxorubicin, Etoposide, and Prednisone (CHEP-BV) Followed by BV Consolidation in Patients with CD30-Positive Peripheral T-Cell Lymphomas

Type of Cancer
Lymphoma
Site
Hackensack
Sponsor
City of Hope
Protocol Number
17058
To Learn More Call
(201)-510-0950